酷代码 AI
菜单
服务商

将下面一段话翻译成英文:“替雷利珠单抗是一种抗pd-1免疫检查点抑制剂,广泛应用于多种肿瘤的免疫治疗中,其可能引发免疫相关性不良反应,免疫相关性糖尿病为罕见但严重的并发症之一,发病迅速且不可逆,通常伴随糖尿病酮症酸中毒的急性发作。该文报道1例替雷利珠单抗注射液致免疫相关性糖尿病的病例,通过分析现有文献和临床案例,总结替雷利珠单抗引发免疫相关性糖尿病的临床特征,探讨免疫检查点抑制剂致糖尿病不良反应机制与处理、药学监护,以期在临床使用中警惕抗pd-1免疫检查点抑制剂引起的免疫相关性糖尿病。”

Tislelizumab is an anti-PD-1 immune checkpoint inhibitor that is widely used in the immunotherapy of various tumors. It may cause immune-related adverse reactions. Immune-related diabetes is one of the rare but serious complications, with rapid and irreversible onset, and is often accompanied by acute attacks of diabetic ketoacidosis. This article reports a case of immune-related diabetes caused by tislelizumab injection. By analyzing the existing literature and clinical cases, the clinical characteristics of immune-related diabetes caused by tislelizumab are summarized, and the mechanism and management of adverse reactions of diabetes caused by immune checkpoint inhibitors and pharmaceutical care are discussed, in order to be vigilant against immune-related diabetes caused by anti-PD-1 immune checkpoint inhibitors in clinical use. [2024-10-11 14:59:37 | AI写代码神器 | 150点数解答]

相关提问
实用工具查看更多
今日油价 [生活类]
图片互转base64 [开发类]
时间转换器 [开发类]
数独游戏 [娱乐类]
经典推箱子 [娱乐类]
AI摸鱼五子棋 [娱乐类]